Evidence map›Paper›PMID 32967980›Full record

ReviewBMJ global health2020

Setting the standard: multidisciplinary hallmarks for structural, equitable and tracked antibiotic policy.

Claas Kirchhelle, Paul Atkinson, Alex Broom, Komatra Chuengsatiansup, Jorge Pinto Ferreira, Nicolas Fortané, Isabel Frost, Christoph Gradmann, Stephen Hinchliffe, Steven J Hoffman and 12 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in BMJ global health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Challenges and shortcomings of antibacterial discovery projects.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2023
    Article
  15. Article
  16. How Antimicrobial Resistance Is Linked to Climate Change: An Overview of Two Intertwined Global Challenges.International journal of environmental research and public health · 2023
    Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Claas KirchhelleSchool of History, University College Dublin, Dublin, Ireland.ORCID 0000-0003-0910-8133
Paul AtkinsonDepartment of Public Health and Policy/ Institute of Infection and Global Health, University of Liverpool, Liverpool, Merseyside, UK.
Alex BroomSchool of Social and Political Sciences, Faculty of Arts and Social Sciences, The University of Sydney, Sydney, New South Wales, Australia.
Komatra ChuengsatiansupPrincess Maha Chakri Sirindhorn Anthropology Center, Bangkok, Thailand.
Jorge Pinto FerreiraAntimicrobial Resistance and Veterinary Products Department, World Organisation for Animal Health, Paris, Île-de-France, France.
Nicolas FortanéIrisso, Paris-Dauphine University, PSL, INRAE, Paris, Île-de-France, France.
Isabel FrostCenter for Disease Dynamics Economics and Policy, Washington, DC, USA.ORCID 0000-0002-0095-0845
Christoph GradmannInstitute for Health and Society, Dept. of Community Medicine and Global Health, University of Oslo, Oslo, Norway.
Stephen HinchliffeGeography, College of Life and Environmental Sciences and Wellcome Centre for Cultures and Environments of Health, University of Exeter, Exeter, Devon, UK.
Steven J HoffmanGlobal Strategy Lab, Dahdaleh Institute for Global Health Research, Faculty of Health and Osgoode Hall Law School, York University, Toronto, Ontario, Canada.ORCID 0000-0002-2064-3711
Javier LezaunInstitute for Science, Innovation and Society, School of Anthropology and Museum Ethnography, University of Oxford, Oxford, Oxfordshire, UK.
Susan NayigaInfectious Diseases Research Collaboration, Kampala, Central Region, Uganda.
Kevin OuttersonSchool of Law, Social Innovation on Drug Program, Boston University, Boston, Massachusetts, USA.
Scott H PodolskyDepartment of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Stephanie RaymondSchool of Social and Political Sciences, Faculty of Arts and Social Sciences, The University of Sydney, Sydney, New South Wales, Australia.
Adam P RobertsDepartment of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool, Liverpool, UK.ORCID 0000-0002-0760-3088
Andrew C SingerPollution, UK Centre for Ecology & Hydrology, Wallingford, UK.
Anthony D SoDepartment of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.
Luechai SringernyuangFaculty of Social Sciences, Mahidol University, Salaya, Nakhon Pathom, Thailand.
Elizabeth TaylerGlobal Coordination and Partnerships, AMR Division, World Health Organisation, Geneva, Switzerland.
Susan Rogers Van KatwykGlobal Strategy Lab, Dahdaleh Institute for Global Health Research, Faculty of Health and Osgoode Hall Law School, York University, Toronto, Ontario, Canada.
Clare I R ChandlerDepartment of Global Health and Development, London School of Hygiene & Tropical Medicine, London, UK clare.chandler@lshtm.ac.uk.ORCID 0000-0001-6499-7522

Funding

Implementing a Multimodal Path to RecOVEry (IMPROVE): Primary and Secondary Prevention of Opioid Overdose in Acute CareR01CE003001 · CE · CAROLINAS MEDICAL CENTER · PI HSU, JOSEPH, SEYMOUR, RACHEL · 2018 to 2020
$2.2M
ACL HHS R01CE003001Medical Research Council MR/S004793/1NCIPC CDC HHS R01 CE003001Wellcome TrustWorld Health Organization 001
6 · The paper itself

Abstract

There is increasing concern globally about the enormity of the threats posed by antimicrobial resistance (AMR) to human, animal, plant and environmental health. A proliferation of international, national and institutional reports on the problems posed by AMR and the need for antibiotic stewardship have galvanised attention on the global stage. However, the AMR community increasingly laments a lack of action, often identified as an 'implementation gap'. At a policy level, the design of internationally salient solutions that are able to address AMR's interconnected biological and social (historical, political, economic and cultural) dimensions is not straightforward. This multidisciplinary paper responds by asking two basic questions: (A) Is a universal approach to AMR policy and antibiotic stewardship possible? (B) If yes, what hallmarks characterise 'good' antibiotic policy? Our multistage analysis revealed four central challenges facing current international antibiotic policy: metrics, prioritisation, implementation and inequality. In response to this diagnosis, we propose three hallmarks that can support robust international antibiotic policy. Emerging hallmarks for good antibiotic policies are: Structural, Equitable and Tracked. We describe these hallmarks and propose their consideration should aid the design and evaluation of international antibiotic policies with maximal benefit at both local and international scales.

Indexed as

Anti-Bacterial AgentsDrug Resistance, BacterialAnimalsHumansPolicyAnti-Bacterial Agentsdiseasesdisordershealth policies and all other topicsinfectionsinjuriespublic health

Identifiers

PMID32967980
PMCPMC7513567

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.